Sangui Biotech International Stock Cash Per Share
| SGBI Stock | USD 0.0002 0.00 0.00% |
Sangui Biotech International fundamentals help investors to digest information that contributes to Sangui Biotech's financial success or failures. It also enables traders to predict the movement of Sangui Pink Sheet. The fundamental analysis module provides a way to measure Sangui Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sangui Biotech pink sheet.
Sangui |
Sangui Biotech International Company Cash Per Share Analysis
Sangui Biotech's Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
| Competition |
In accordance with the recently published financial statements, Sangui Biotech International has a Cash Per Share of 0.0 times. This is 100.0% lower than that of the Healthcare sector and about the same as Drug Manufacturers—Specialty & Generic (which currently averages 0.0) industry. The cash per share for all United States stocks is 100.0% higher than that of the company.
Sangui Cash Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sangui Biotech's direct or indirect competition against its Cash Per Share to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Sangui Biotech could also be used in its relative valuation, which is a method of valuing Sangui Biotech by comparing valuation metrics of similar companies.Sangui Biotech is currently under evaluation in cash per share category among its peers.
Sangui Fundamentals
| Return On Asset | -0.64 | |||
| Profit Margin | (1.27) % | |||
| Operating Margin | (1.50) % | |||
| Current Valuation | 1.68 M | |||
| Shares Outstanding | 209.9 M | |||
| Shares Owned By Insiders | 13.03 % | |||
| Price To Earning | (18.33) X | |||
| Price To Book | 46.44 X | |||
| Price To Sales | 10.09 X | |||
| Revenue | 69.19 K | |||
| Gross Profit | 69.19 K | |||
| EBITDA | (18.44 K) | |||
| Net Income | (63.34 K) | |||
| Cash And Equivalents | 30.47 K | |||
| Total Debt | 48.9 K | |||
| Debt To Equity | 0.05 % | |||
| Current Ratio | 0.07 X | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (140.46 K) | |||
| Beta | 0.22 | |||
| Market Capitalization | 902.58 K | |||
| Total Asset | 130.79 K | |||
| Retained Earnings | (37 M) | |||
| Net Asset | 130.79 K |
About Sangui Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sangui Biotech International's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sangui Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sangui Biotech International based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Sangui Pink Sheet
Sangui Biotech financial ratios help investors to determine whether Sangui Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sangui with respect to the benefits of owning Sangui Biotech security.